Introduction to the Bridges in Life Sciences
Збережено в:
| Дата: | 2011 |
|---|---|
| Автор: | |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут молекулярної біології і генетики НАН України
2011
|
| Назва видання: | Вiopolymers and Cell |
| Теми: | |
| Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/156510 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Introduction to the Bridges in Life Sciences / G. Vari // Вiopolymers and Cell. — 2011. — Т. 27, № 2, доп. — С. 2-5. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
irk-123456789-156510 |
|---|---|
| record_format |
dspace |
| spelling |
irk-123456789-1565102019-06-19T01:25:54Z Introduction to the Bridges in Life Sciences Vari, G. Bridges in Life Sciences 6th Annual Scientific Conference 2011 Article Introduction to the Bridges in Life Sciences / G. Vari // Вiopolymers and Cell. — 2011. — Т. 27, № 2, доп. — С. 2-5. — англ. 0233-7657 http://dspace.nbuv.gov.ua/handle/123456789/156510 en Вiopolymers and Cell Інститут молекулярної біології і генетики НАН України |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| language |
English |
| topic |
Bridges in Life Sciences 6th Annual Scientific Conference Bridges in Life Sciences 6th Annual Scientific Conference |
| spellingShingle |
Bridges in Life Sciences 6th Annual Scientific Conference Bridges in Life Sciences 6th Annual Scientific Conference Vari, G. Introduction to the Bridges in Life Sciences Вiopolymers and Cell |
| format |
Article |
| author |
Vari, G. |
| author_facet |
Vari, G. |
| author_sort |
Vari, G. |
| title |
Introduction to the Bridges in Life Sciences |
| title_short |
Introduction to the Bridges in Life Sciences |
| title_full |
Introduction to the Bridges in Life Sciences |
| title_fullStr |
Introduction to the Bridges in Life Sciences |
| title_full_unstemmed |
Introduction to the Bridges in Life Sciences |
| title_sort |
introduction to the bridges in life sciences |
| publisher |
Інститут молекулярної біології і генетики НАН України |
| publishDate |
2011 |
| topic_facet |
Bridges in Life Sciences 6th Annual Scientific Conference |
| url |
http://dspace.nbuv.gov.ua/handle/123456789/156510 |
| citation_txt |
Introduction to the Bridges in Life Sciences / G. Vari // Вiopolymers and Cell. — 2011. — Т. 27, № 2, доп. — С. 2-5. — англ. |
| series |
Вiopolymers and Cell |
| work_keys_str_mv |
AT varig introductiontothebridgesinlifesciences |
| first_indexed |
2025-07-14T08:51:22Z |
| last_indexed |
2025-07-14T08:51:22Z |
| _version_ |
1837611701600518144 |
| fulltext |
2
Introduction to the Bridges in Life Sciences
In 2006 Cedars–Sinai Medical Center (CSMC), Los Angeles, CA, USA with eleven CEE universities and
academic organizations from six countries (Croatia, Czech Republic, Hungary, Romania, Slovakia, and
Ukraine) formed the Regional Cooperation for Health, Science and Technology (RECOOP HST)
Consortium.
Members:
Cedars – Sinai Medical Center, Los Angeles, USA
School of Medicine University J. J. Strossmayer Osijek, Croatia
University of Split School of Medicine, Croatia
Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic
University of Debrecen, Hungary
University of Pecs, Hungary
University of Szeged, Hungary
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Slovak Medical University, Bratislava, Slovakia
Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, Kyiv, Ukraine
Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine
Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv, Ukraine
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Associate Members
Amosov National Institute of Cardiovascular Surgery, Academy of Medical Sciences of Ukraine, Kyiv,
Ukraine
Comenius University in Bratislava, Slovakia
Faculty of Pharmacy, University of Copenhagen, Denmark
IKEM ‐ Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Institute of Macromolecular Chemistry Academy of Sciences, Czech Republic
Institute of Physics, Wroclaw University of Technology, Wroclaw, Poland
University Hospital in Hradec Kralove, Czech Republic
The founders of RECOOP HST Consortium decided to review the scientific progress in the Consortium
therefore organized the Bridges in Life Sciences Meetings.
3
The first “Bridges in Life Sciences” meeting was before the formation of the RECOOP organized by
Cedars–Sinai Medical Center in collaboration with Fogarty International Center, National Institute (NIH)
of Health USA, and it was held in Budapest, Hungary in October 2003. That meeting highlighted US –
Central and Eastern European research collaborations in eight scientific tracks, providing an excellent
networking opportunity for NIH‐supported scientists from over ten CEE countries. The eight priority
areas were: cancer, reproductive health, cardiovascular health, infectious diseases, neurosciences,
functional genomics/proteomics and cell biology, environmental health, and behavioral health studies.
2nd Annual Scientific Meeting was on October 5, 2007 in Pecs, Hungary
3rd Annual Scientific Meeting in Zagreb, Croatia on October 4, 2008.
The Bridges in Life Sciences 4th Annual Scientific Meeting took place in Debrecen, Hungary on April 4 – 5,
2009. In Debrecen the RECOOP Consortium provided opportunities for young scientists to discuss the
major public health problems in the region and engage with senior scientists from RECOOP, Visegrad
Group (V4) academic organizations and NIH funded PIs from the USA with robust collaborative works in
the CEE Countries.
The Bridges in Life Sciences 5th Annual Scientific Meeting was organized for the RECOOP HST member
organizations and also for Universities and Research Institutes in Lviv, Ukraine on April 9 – 11, 2010
RECOOP HST Consortium was formed to help physicians, researchers and scientists to share new
discoveries and develop better patient care. The Consortium enhances the research and development
success of the participating organizations via training young scientists, and implementing multinational
and multidisciplinary collaborations.
The main activity of the RECOOP HST Consortium is research networking to build multinational and
multidisciplinary research teams to be able to investigate complex diseases that are the major public
health problems (cardiovascular, cancer, neurodegenerative diseases, and women’s health and human
development) in Central and Eastern Europe and worldwide
Research Networks:
Women's Health (WH) and Cardiovascular Diseases (CVD) Research Network
Mother and Child Health Research Network
Translational and Nano – Bio – Technology Research for Cancer Treatment
Support Networks
Network for Animal Care & Use in Research
Clinical Trial Site Management Network
Intellectual Property Education, Scholarship and Grantsmenship Network
4
Dual Use of Biotechnology Training Network
Innovation Management Network
The Research and Support Networks help building multinational and multidisciplinary research teams
to be able to investigate complex diseases that are the major public health problems like women’s
health and gender differences in cardiovascular diseases, preterm birth, and cancer.
The main cause of women's mortality in the Central and Eastern European (CEE) region is cardiovascular
disease (CVD) and cancer. Therefore, most health care professionals recognize CVD in women as a
critical health problem in this area. One of the problems is insufficient data regarding CVD and its risk
factors in women worldwide. The goal of the WH&CVD Network is investigating the gender differences
in CVD and its management.
The other major health care problem, the relative neglect of preterm birth (PTB) is linked to data gaps
on the global toll of prematurity, including the extent of associated death and disability. Partners of
Mother and Child Health Research Network (MOCHEA) are making an undertaking to identify the risk
factors of preterm birth, and the Network’s major goal to assess the risk factors leading to preterm birth
in Central and Eastern Europe (CEE).
Cancer metastases are the major contributing factors to the lethality and morbidity of the patients. Thus
far the majority of the new‐targeted therapies are designed based on the understanding of inter‐ and
intra‐cellular signaling pathways of cancer cells and the unique biology of organ‐specific expression of
molecular targets. Since the mortality of cancer has not been improved significantly, new approaches
are needed to reduce the occurrence and the progression of human cancer. The Translational and Nano
–Bio‐Technology Research Network aims to bring together scientists from all research areas of Nano
biotechnologies and develop new medical diagnostic and treatment modalities. The Research Network
will develop multinational ‐ multidisciplinary strategic research plan and will execute it to improve the
quality of life for women diagnosed with breast and ovarian cancer, men with prostate cancer and both
genders with lung and brain cancer.
The RECOOP HST Consortium Support Networks will provide infrastructural reinforcement for the
research networks from preclinical use of research animals to randomized controlled clinical research.
The Consortium provides advice and guidance for biosafety and bio‐security in addition to training
scientists for sound scientific communication in their manuscripts and presentation. It also helps with
better understanding of innovation, bridges the innovation gaps in methodologies, procedures and
products and steps toward more comprehensive and “state of the art” scientific solutions.
The RECOOP HST Consortium Animal Care and Use (CAUSE) Network closes the gaps between basic and
clinical sciences and translates complex biological discoveries via preclinical animal research into
medical advances. RECOOP HST Consortium CAUSE Network performed Program Status Evaluation (PSE)
and SWOT analysis, and as a next step the Network creates guidelines and standard operating
procedure (SOP) for the animal facilities. The CAUSE Network outlines biomethodology training
programs for young researchers and PhD students for the use of research animals.
5
The members of RECOOP HST Clinical Trial Site Management Network (CTSMN) understood that many
treatments are used without sound evidence and would like advocating the use of randomized
controlled clinical research to prove efficacy of the diagnosis and the treatments. The CTSMN’s goal is
helping partner organization to establish clinical research training integrating biochemistry,
immunology, genetics, and microbiology, underscoring their interrelationships in understanding the
mechanisms of human body.
Members of the BIOSECURE Network will work to improve ways to control and manage biosafety and
bio‐security issues at the academic institutes and universities in the RECOOP HST Consortium. The
Network provides advice and guidance for higher education in biological research and technologies,
which have potential to be misused and would pose biologic threat to the public health or national
security.
The International Research and Innovation Management Training (IRIM) Network inspires young
scientists and clinical researchers for the creative thinking. It helps to learn how to make decision on
“publish and disclose” or “publish and protect” procedure during researchers’ scientific work. The IRIM
Network utilizes World Intellectual Property Organization (WIPO) World Wide Academy (WWA) Distance
Learning (DL) courses for faculty members, managers, young scientists, clinicians and Ph.D. students as
regular credit requirement to complete their qualification and to defend their doctoral thesis. The IRIM
Network trains young scientists for proper and scientifically sound communication of their research
results in their manuscripts and presentations. The Network provides practical training on the
presentation of data in the manuscript from the “Introduction, Methods, Results and Discussion” to the
“Conclusion” sections of the manuscript and guides the young scientists organizing data as tables and
graphs and presenting results of statistical analysis.
The Innovation Management Network explores and enhances the research and development outputs
of the member universities and/or and academic organizations, creates critical mass of scientifically
sound innovative biotechnologies and exploits the outcomes on the global market.
“The RECOOP HST Consortium explores and enhances the LOCAL scientific outputs of
the partner organizations, creates critical mass of scientifically sound innovative
biotechnologies at the REGIONAL level and exploits the outcomes on the GLOBAL
market.” TM
Sandor G. Vari, MD,
Director, International Research and Innovation Management
Program Cedars‐Sinai Medical Center & General Manager of the
RECOOP HST Consortium
|